The global clopidogrel bisulfate market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Clopidogrel bisulfate is used for the treatment of serious or life-threatening problems with the heart and blood vessels. It is given to people who have had a stroke, heart attack, or severe chest pain. The major factor for the growth of the market during the forecast period is the increasing demand for the medication due to the prevalence of the heart-related disease.
According to the American Heart Association, in 2018, coronary heart disease was the major cause of mortality that accounted for 365,744 mortalities approximately 13% of mortalities in the US. Additionally, as per the same source, an American will have a heart attack approximately in every 39 seconds. Furthermore, stroke accounted for about 1 of every 19 deaths in the US in 2018. Hence, the rising prevalence of heart diseases is driving the growth of the global clopidogrel bisulfate.
To Request a Sample of our Report on Global Clopidogrel Bisulfate Market: https://www.omrglobal.com/request-sample/clopidogrel-bisulfate-market
Some major key players in the market include Sanofi S.A., Bristol-Myers Squibb Co., and Sun Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2017, Sanofi-aventis and Bristol-Myers Squibb Co. announced that their PLAVIX (clopidogrel bisulfate) has been approved by the FDA for the treatment of patients with most severe type of heart attack.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Sanofi S.A., Bristol-Myers Squibb Co., and Sun Pharmaceutical Industries Ltd., among others.
A full Report of Global Clopidogrel Bisulfate Market is Available @ https://www.omrglobal.com/industry-reports/clopidogrel-bisulfate-market
Global Clopidogrel Bisulfate Market Report by Segment
By Type
- 75 mg Tablets
- 300 mg Tablets
By End-User
- Hospitals
- Drug Stores
- Others
Global Clopidogrel Bisulfate Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/clopidogrel-bisulfate-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
